Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Condition(s):Urethral Neoplasms; Neoplasms, Urethral; Cancer of the Urethra; Urethral CancerLast Updated:March 13, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Urethral Neoplasms; Neoplasms, Urethral; Cancer of the Urethra; Urethral CancerLast Updated:March 13, 2024Completed
Condition(s):Urinary Tract CancerLast Updated:September 25, 2014Terminated
Condition(s):Urinary Tract CancerLast Updated:February 11, 2015Completed
Condition(s):Bladder Cancer; Urothelial CarcinomaLast Updated:July 11, 2022Completed
Condition(s):Urothelial CancerLast Updated:February 6, 2024Active, not recruiting
Condition(s):Urothelial CarcinomaLast Updated:April 18, 2023Withdrawn
Condition(s):Urothelial Carcinoma Associated 1 RNA, HumanLast Updated:September 8, 2023Completed
Condition(s):Metastatic Urothelial Carcinoma; Bladder CancerLast Updated:March 20, 2024Active, not recruiting
Condition(s):Ureteral Cancer; Urothelial Cancer; Bladder CancerLast Updated:March 27, 2024Active, not recruiting
Condition(s):Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and UreterLast Updated:July 1, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.